HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

José-Alain Sahel Selected Research

Chorioretinitis

10/2022Clinical Features and Multimodal Imaging in Atypical Posterior Uveitis Secondary to Bartonella Henselae Infection.
3/2022NEW OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FINDINGS ON AN INTRARETINAL VASCULAR PROCESS SECONDARY TO TOXOPLASMA RETINOCHOROIDITIS: 2 CASE REPORTS.
1/2022Indocyanine Green Angiography Features in Acute Syphilitic Posterior Placoid Chorioretinitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


José-Alain Sahel Research Topics

Disease

26Retinitis Pigmentosa (Pigmentary Retinopathy)
06/2022 - 05/2004
20Macular Degeneration (Age-Related Maculopathy)
04/2022 - 10/2005
18Blindness (Hysterical Blindness)
10/2022 - 04/2007
18Retinal Degeneration
04/2022 - 08/2003
16Cone-Rod Dystrophies
06/2022 - 02/2005
13Inflammation (Inflammations)
03/2021 - 01/2011
11Ganglion Cysts (Ganglion)
09/2021 - 08/2005
11Retinal Diseases
01/2020 - 01/2012
10Diabetic Retinopathy (Retinopathy, Diabetic)
04/2021 - 08/2005
9Retinal Dystrophies
06/2022 - 04/2007
7congenital stationary Night blindness
09/2021 - 02/2012
7Retinal Detachment (Retinal Detachments)
11/2020 - 01/2011
7Glaucoma
11/2020 - 08/2005
6Atrophy
12/2021 - 11/2013
6Vision Disorders (Hemeralopia)
10/2021 - 02/2005
5Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy)
10/2021 - 03/2014
5Optic Atrophy
01/2015 - 01/2012
4Edema (Dropsy)
03/2022 - 01/2015
4Usher Syndromes (Usher Syndrome)
01/2022 - 10/2012
4Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 05/2015
4Macular Edema
11/2020 - 10/2005
4Photophobia (Light Sensitivity)
01/2020 - 02/2015
4White Dot Syndromes
10/2017 - 09/2012
4Choroidal Neovascularization
01/2017 - 01/2014
4Inborn Genetic Diseases (Disease, Hereditary)
02/2016 - 05/2004
3Chorioretinitis
10/2022 - 01/2022
3Uveitis
01/2022 - 01/2013
3Phototoxic Dermatitis (Phototoxicity)
01/2020 - 01/2013
3Stargardt Disease
01/2020 - 10/2014
3Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
05/2016 - 07/2005
3Alzheimer Disease (Alzheimer's Disease)
10/2015 - 12/2012
2Gliosis
03/2022 - 09/2013
2Epiretinal Membrane (Epiretinal Membranes)
03/2022 - 09/2013
2Retinitis
03/2022 - 03/2010
2Enhanced S-Cone Syndrome
10/2021 - 04/2007
2Leber Congenital Amaurosis
10/2021 - 02/2016
2Night Blindness (Nyctalopia)
09/2021 - 01/2016
2Cone Dystrophy
06/2021 - 10/2014
2Choroideremia
01/2021 - 10/2014
2Proliferative Vitreoretinopathy
12/2019 - 09/2013
2Vitelliform Macular Dystrophy
12/2019 - 10/2014
2Pathologic Processes
11/2019 - 01/2014
2Mitochondrial Diseases (Mitochondrial Disease)
01/2018 - 01/2012
2Posterior Uveitis
01/2018 - 12/2011

Drug/Important Bio-Agent (IBA)

83Retinaldehyde (Retinal)IBA
10/2022 - 05/2004
22Proteins (Proteins, Gene)FDA Link
04/2022 - 08/2003
6Messenger RNA (mRNA)IBA
03/2022 - 01/2012
6Indocyanine Green (Cardio-Green)FDA LinkGeneric
03/2022 - 02/2010
5Fluorescein (Funduscein)FDA LinkGeneric
02/2020 - 10/2005
4Retinal Pigments (Pigments, Visual)IBA
04/2022 - 01/2013
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2022 - 01/2017
4Interleukin-6 (Interleukin 6)IBA
01/2022 - 02/2015
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 05/2004
4Glucose (Dextrose)FDA LinkGeneric
11/2021 - 10/2017
4A2-E (N-retinylidene-N-retinylethanolamine)IBA
01/2021 - 01/2013
4OpsinsIBA
01/2020 - 02/2015
4TaurineFDA Link
07/2014 - 01/2012
3DNA (Deoxyribonucleic Acid)IBA
07/2022 - 03/2010
3Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022 - 01/2018
3CytokinesIBA
01/2022 - 05/2010
3Rhodopsin (Visual Purple)IBA
10/2021 - 07/2010
3Silicone OilsIBA
10/2021 - 09/2013
3norbixinIBA
01/2021 - 01/2016
3Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2013
3DystrophinIBA
05/2016 - 01/2014
3NeuroglobinIBA
06/2014 - 12/2012
2GTP Phosphohydrolases (GTPases)IBA
06/2022 - 10/2021
2Protein Isoforms (Isoforms)IBA
06/2022 - 10/2015
2Monoclonal AntibodiesIBA
04/2022 - 10/2021
2Red Fluorescent ProteinIBA
04/2022 - 10/2021
2Peptide Hydrolases (Proteases)FDA Link
04/2022 - 09/2012
2RNA (Ribonucleic Acid)IBA
04/2022 - 01/2014
2Small Interfering RNA (siRNA)IBA
04/2022 - 12/2012
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
04/2022 - 10/2021
2Green Fluorescent ProteinsIBA
04/2022 - 10/2021
2Beclin-1IBA
04/2022 - 10/2021
2ChemokinesIBA
01/2022 - 05/2010
2AntigensIBA
10/2021 - 01/2017
2TubulinIBA
10/2021 - 12/2017
2Immunoglobulins (Immunoglobulin)IBA
09/2021 - 01/2014
2Leucine (L-Leucine)FDA Link
09/2021 - 01/2014
2Streptozocin (Streptozotocin)FDA Link
01/2021 - 01/2013
2salicylhydroxamic acid (SHAM)IBA
01/2021 - 12/2020
2Insulin (Novolin)FDA Link
11/2020 - 01/2013
2Glutamic Acid (Glutamate)FDA Link
01/2020 - 09/2005
2SuspensionsIBA
01/2020 - 12/2017
2Thrombospondin 1IBA
01/2020 - 01/2015
2AutoantibodiesIBA
01/2020 - 01/2017
2Complement System Proteins (Complement)IBA
01/2018 - 01/2016
2AntibodiesIBA
01/2017 - 01/2013
2Complement Factor H (Factor H)IBA
01/2017 - 09/2012

Therapy/Procedure

26Therapeutics
03/2022 - 01/2005
6Visual Prosthesis
11/2020 - 04/2012
5Transplantation
01/2021 - 05/2004
4Vitrectomy
10/2021 - 08/2013
4Lasers (Laser)
07/2019 - 01/2008
3Intravitreal Injections
01/2021 - 01/2013
3Cell- and Tissue-Based Therapy (Cell Therapy)
02/2016 - 02/2005
2Prostheses and Implants (Prosthesis)
11/2020 - 01/2020
2Activities of Daily Living (ADL)
10/2020 - 11/2018